" class="no-js "lang="en-US"> Mario Amaro - Medtech Alert
Sunday, October 19, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Mario Amaro

Mario Amaro

About Mario Amaro

USN Veteran turned healthcare tech founder. Helping HCPs build and launch medical practices with no leases and no contracts. #DocSpaceCrew #DocSpacer

Related Story

Fundraising

 DocSpace

DocSpace, Houston-Based Digital Health Startup, Raises $1.2 Million to Help Clinicians Build and Launch Independent Practices

August 20 2021

DocSpace, a digital health commerce platform that helps clinicians start, manage, and grow tech-enabled private […]